Webinar: Keeping Claims on Track During COVID-19

Helen Froehlich

Senior Vice President

Mariellen Blue

National Director, Case Management Services

Event Details

Start: April 23, 2020 @ 2:00PM EDT End: @ Location: Online Event

Case management provides a crucial role in keeping claims on track and achieving return to work or maximum medical improvement. However, as COVID-19 restrictions present new challenges in claims management, payers are asking what to do and how to ensure injured employees stay on track with their care protocol and meet their RTW/MMI goals.

Genex experts shared important insights based on clinical best practices and real-life case strategies to help you move claims forward in the face of COVID-19 restrictions, challenges, and possible exposure.

Download a copy of the slides and watch the on-demand webinar below.

Speakers

Helen Froehlich SVP, Utilization Management	Mariellen Blue, RN, CCM National Director of Case Management Services	Bobbie Doyle, RN, BSN, CCM Case Management Regional Director

More stories

Mitchell News Release

Mitchell Diagnostics System Enhanced for FCA Secure Gateway and Turbo-Speed Scanning

December 18, 2019

Mitchell's all-makes scan tools from Bosch offer full access to FCA secure vehicle networks and dramatic speed improvements for pre- and post-scanning.

Workers' Comp Blog

Warnings about impurities in Zantac® and blood pressure medicines

December 16, 2019

In September 2019, the U.S. Food and Drug Administration (FDA) reported the discovery of low levels of an impurity in brand, generic, and over- the-counter (OTC) versions of a popular heartburn medication, Zantac® (Ranitidine HCl) 1, prompting a flurry of manufacturer recalls, national distribution halts, and product removals from retail pharmacy shelves. Ranitidine is an H2 (Histamine-2) blocker approved as a prescription medicine for treatment and prevention of GI ulcers and gastroesophageal reflux disease (GERD). OTC versions are approved for relief of acid indigestion and sour stomach. H2 blockers (like Tagamet, Pepcid, and Zantac) act by reducing the amount of acid produced by cells lining the stomach.

Workers' Comp Podcast

Peter Rousmaniere Part 1: Comp’s Evolutions and Influencers

December 12, 2019

When you think of industry icons in workers’ comp, Peter Rousmaniere is among the select few at the top of the list. For more than 30 years, Peter has been a major influencer in workers’ comp, especially over the past couple of decades as a popular columnist. Last month, Peter announced his well-deserved retirement, so we asked him to join us on Inside Workers’ Comp to talk about his celebrated career and offer insights on the industry. The conversation was so profound that we made it into a two-parter. Here’s Part 1.

Mitchell News Release

Mitchell Issues 4th Quarter 2019 Industry Trends Report

December 10, 2019

The impact of emotion AI on “humane” claims automation; the complexities of windshield repair; and actionable insights for maximizing value of claims data and analytics.

Workers' Comp Blog

What moved the state of Ohio to drop OxyContin® from their formulary?

December 9, 2019

The state of Ohio, among the hardest hit in the nation for opioid overdose deaths, has undertaken a number of measures to meet the crisis as it has evolved. A review of opioid use in the injured worker population, completed in 2011, revealed an alarming number (73%) were filling opioid prescriptions.1 A closed formulary, expanded access to antidote products (naloxone), and opioid focused prescribing guidelines have all followed since and have contributed to some reductions in prescribing and the prevalence of opioid use.

Mitchell Article

Average Length of Rental for Repairable Vehicles: Q3 2019

December 9, 2019

Average Length of Rental (LOR) for Q3 2019 landed at 12.4 days in the United States, an increase of 0.4 days compared to Q3 2018. Once again, there was very little consistency between regions and states or with Q2’s numbers. The Mid-Atlantic and Midwest regions produced the largest increases at 0.5 days each.